Co-Founder & CEO
Michał Ryś - co-founder and CEO of DrOmnibus Therapeutics, company which creates digital therapeutics for children with low-functioning autism. Prior to DrOmnibus, he spent over 11 years working in finance and investments (VC), including own business, that was exited in 2013. For the last 7 years the board member of the NGO, that takes care of almost 100 children, mainly with autism. Graduated from Jagiellonian University (Poland), KU Leuven (Belgium), University of Groningen (The Netherlands) and Uppsala University (Sweden). Awards: New Europe 100: Eastern Europe’s emerging technology stars (Financial Times) and Creative in business (Brief). Passionate about digital health and its influence on health economy.